Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization

Autor:	Mohammed S. A. Suhail, Charles W. Nutting, Sabine Schirm, Samir Kanani, Michael Cohn, Fred M. Moeslein, Kazim H. Narsinh, Samuel G. Putnam, David Ball, Alain Drooz, Steven C. Rose, Andrew S. Kennedy, Naif Alsaikhan, Michael Savin, Jeet Minocha, Eduardo Ehrenwald, Eric A. Wang, Carl K. Hoh, Douglas M. Coldwell, Mark Van Buskirk, Kenneth G. Thurston, Navesh K. Sharma, Steven J. Cohen
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty Lung medicine.diagnostic_test biology business.industry medicine.medical_treatment Magnetic resonance imaging Retrospective cohort study Gastroenterology 030218 nuclear medicine & medical imaging Shunting 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Carcinoembryonic antigen 030220 oncology & carcinogenesis Internal medicine Angiography medicine biology.protein Radiology Nuclear Medicine and imaging Embolization business Survival rate
Zdroj:	Radiology. 282:281-288
ISSN:	1527-1315 0033-8419
DOI:	10.1148/radiol.2016152100
Popis:	In patients undergoing hepatic radioembolization for metastatic colorectal adenocarcinoma, increased lung shunt fraction is predictive of significantly decreased survival but demonstrates only a weak correlation with serum carcinoembryonic antigen levels and tumor-to-liver volume ratio and no correlation to the presence or absence of extrahepatic metastatic disease.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8e3121aab3a919b10ae8be44564830e0 https://doi.org/10.1148/radiol.2016152100 Zobrazit plný text záznamu